If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
association |
total |
8
|
9
|
38
|
4
|
0 |
1
|
60
|
Gene and significance breakdown #
Total genes and gene combinations: 44
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
association |
total |
COL4A4
|
2
|
1
|
2
|
0 |
0 |
5
|
CFHR1
|
0 |
0 |
3
|
0 |
0 |
3
|
COL4A3, MFF-DT
|
0 |
0 |
2
|
1
|
0 |
3
|
FN1
|
0 |
0 |
3
|
0 |
0 |
3
|
PKD1
|
1
|
0 |
2
|
0 |
0 |
3
|
APOA1
|
0 |
0 |
2
|
0 |
0 |
2
|
CFHR5
|
0 |
0 |
2
|
0 |
0 |
2
|
EHHADH
|
0 |
0 |
2
|
0 |
0 |
2
|
LRRC37A2, WNT9B
|
0 |
2
|
0 |
0 |
0 |
2
|
ACTN4
|
0 |
0 |
1
|
0 |
0 |
1
|
ALMS1
|
0 |
1
|
0 |
0 |
0 |
1
|
ANLN
|
0 |
0 |
1
|
0 |
0 |
1
|
ARHGDIA
|
0 |
0 |
1
|
0 |
0 |
1
|
ATIC, FN1
|
0 |
0 |
1
|
0 |
0 |
1
|
AXDND1, NPHS2
|
0 |
1
|
0 |
0 |
0 |
1
|
CEL
|
0 |
0 |
1
|
0 |
0 |
1
|
CFH
|
0 |
1
|
0 |
0 |
0 |
1
|
CFI
|
0 |
0 |
0 |
1
|
0 |
1
|
COL4A1
|
0 |
0 |
1
|
0 |
0 |
1
|
COL4A5
|
1
|
0 |
0 |
0 |
0 |
1
|
CUBN
|
1
|
0 |
0 |
0 |
0 |
1
|
DSTYK
|
0 |
0 |
1
|
0 |
0 |
1
|
ETFB
|
0 |
0 |
1
|
0 |
0 |
1
|
FN1, LOC126806496
|
0 |
0 |
1
|
0 |
0 |
1
|
FN1, LOC126806498
|
0 |
0 |
1
|
0 |
0 |
1
|
FREM1
|
0 |
0 |
1
|
0 |
0 |
1
|
GANAB
|
0 |
0 |
1
|
0 |
0 |
1
|
GATA3
|
1
|
0 |
0 |
0 |
0 |
1
|
INF2
|
0 |
0 |
0 |
1
|
0 |
1
|
LIPJ, LOC130004283, RNLS
|
0 |
0 |
0 |
0 |
1
|
1
|
LOC107982234, WT1
|
0 |
0 |
1
|
0 |
0 |
1
|
LOC129992813, PKD2
|
1
|
0 |
0 |
0 |
0 |
1
|
MKS1
|
1
|
0 |
0 |
0 |
0 |
1
|
MT-TF
|
0 |
0 |
1
|
0 |
0 |
1
|
NHERF1
|
0 |
0 |
1
|
0 |
0 |
1
|
NPHS2
|
0 |
1
|
0 |
0 |
0 |
1
|
PASK
|
0 |
0 |
1
|
0 |
0 |
1
|
SLC13A5
|
0 |
1
|
0 |
0 |
0 |
1
|
SOX17
|
0 |
0 |
1
|
0 |
0 |
1
|
TBX18
|
0 |
0 |
1
|
0 |
0 |
1
|
TFCP2L1
|
0 |
1
|
0 |
0 |
0 |
1
|
TTC21B
|
0 |
0 |
0 |
1
|
0 |
1
|
UMOD
|
0 |
0 |
1
|
0 |
0 |
1
|
ZNF423
|
0 |
0 |
1
|
0 |
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
association |
total |
Cavalleri Lab, Royal College of Surgeons in Ireland
|
2
|
4
|
33
|
4
|
0 |
43
|
Centre for Mendelian Genomics, University Medical Centre Ljubljana
|
4
|
0 |
2
|
0 |
0 |
6
|
Yale Center for Mendelian Genomics, Yale University
|
0 |
3
|
0 |
0 |
0 |
3
|
Molecular Diagnostics Lab, Nemours Children's Health, Delaware
|
1
|
0 |
0 |
0 |
0 |
1
|
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
|
0 |
1
|
0 |
0 |
0 |
1
|
Bioinformatics dept., Datar Cancer Genetics Limited, India
|
1
|
0 |
0 |
0 |
0 |
1
|
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
|
0 |
0 |
1
|
0 |
0 |
1
|
NIHR Bioresource Rare Diseases, University of Cambridge
|
0 |
1
|
0 |
0 |
0 |
1
|
Institute of Human Genetics, University of Leipzig Medical Center
|
0 |
0 |
1
|
0 |
0 |
1
|
Center for Personalized Medicine, Children's Hospital Los Angeles
|
0 |
0 |
1
|
0 |
0 |
1
|
Bioinformatics & Molecular Biology Unit, Faculty of Science, Al-Azhar University
|
0 |
0 |
0 |
0 |
1
|
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.